Sutro Biopharma (STRO) EBT Margin Growth (3y) (2020 - 2025)
Sutro Biopharma (STRO) EBT Margin Growth (3y) (2020 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
49,756.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
441.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Sutro Biopharma |
252.04 Mn |
252.04 Mn |
- |
-30,899.00 |
| Date | Value |
|---|
| Dec 31, 2025 |
-30,899.00 |
| Sep 30, 2025 |
-50,908.00 |
| Jun 30, 2025 |
6,562.00 |
| Mar 31, 2025 |
-48,283.00 |
| Dec 31, 2024 |
140,458.00 |
| Sep 30, 2024 |
-20,979.00 |
| Jun 30, 2024 |
-24,779.00 |
| Mar 31, 2024 |
-31,334.00 |
| Dec 31, 2023 |
37,809.00 |
| Sep 30, 2023 |
-20,943.00 |
| Jun 30, 2023 |
-16,802.00 |
| Mar 31, 2023 |
-11,781.00 |
| Dec 31, 2022 |
-26,995.00 |
| Sep 30, 2022 |
2,768.00 |
| Jun 30, 2022 |
4,737.00 |
| Mar 31, 2022 |
-47,101.00 |
| Dec 31, 2021 |
-35,002.00 |
| Sep 30, 2021 |
-23,219.00 |
| Jun 30, 2021 |
18,040.00 |
| Mar 31, 2021 |
7,377.00 |
